| GSRX Industries (OTCQB: GSRX) Reports Q4 Revenue Up 135% and Reaffirms Q1 Record Revenue Guidance |
| |
|
GSRX Industries (OTCQB: GSRX) reported its fourth quarter results last week. Total Q4 revenue was up 135% from the prior quarter ended September 30, reaching more than $1.6 million, while gross profit surged 188% to $733,585. The company also reaffirmed its first quarter 2019 guidance, expecting $2.9 million total revenue, with gross profit margin rising to more than 51%.
Key Quote: "We see strong demand across all our operations and look forward to commencing nonvolatile extraction and lite manufacturing soon. Our tremendous increases in revenues each quarter confirm the solid growth of our overall business operations.” Les Ball, CEO
What's Next: GSRX expects to report first quarter results in May. Overall, the company is doing a great job of building out its vertically integrated operations in Puerto Rico and California, and with its recent entrance into the CBD market, strong revenue growth is expected to continue.
Disclosure
GSRX Industries (OTCQB: GSRX) is a client of RedChip Companies. RedChip Companies, Inc. received 1,000,000 registered shares of GSRX for consulting services. Be advised RedChip intends to sell some or all of its shares at any time, including when you are buying.
|
|
| |
|
| Piedmont Lithium (NASDAQ: PLL) Joins the RedChip Nation |
| |
|
Piedmont Lithium Limited (ASX: PLL; Nasdaq: PLL) holds a 100% interest in the Piedmont Lithium Project (“Project”) located within the world-class Carolina Tin-Spodumene Belt (“TSB”) and along the trend to the Hallman Beam and Kings Mountain mines, historically providing most of the Western world’s lithium between the 1950s and the 1980s. The TSB has been described as one of the largest lithium provinces in the world and is located approximately 25 miles west of Charlotte, North Carolina.
Key Quote: "We continue to make good progress in several areas critical to our strategy, and remain on-track to begin construction in early-2020, consistent with the schedule we established in late-2017. As the only conventional lithium project in the USA, we have attracted considerable strategic interest and have engaged in initial conversations with parties in the lithium, mining, chemicals, battery, automotive, and private equity sectors." Keith D. Phillips, President & CEO
Disclosure
Piedmont Lithium (PLL) is a client of RedChip Companies, Inc. PLL agreed to pay RedChip Companies, Inc. a monthly cash fee for six (6) months of RedChip investor awareness services
|
|
| |
|
| eMARINE Global (OTC: EMRN) Attracts Industry Attention at CIRM 2019 Annual Conference |
| |
|
eMARINE Global (OTC: EMRN), a leading provider of information and communications technology (ICT) for the maritime industry, accompanied delegates from Hyundai Global Service (HGS) at the CIRM (Comite International Radio-Maritime) Annual Conference 2019 Vouliagmeni, Greece.
Why It Matters: HGS announced the company’s strategic plan for “total care service through digital transformation” at the conference. During the presentation, Mr. JinHyun Park, HGS lead delegate, proudly introduced their digital innovation center, where ships globally are monitored for their location, environment, voyage optimization, engine operation status, and pre-emptive maintenance. Ship owners and operators benefit from analysis reports by ship or by fleet, provided from the HGS digital innovation center. The service is not limited to warrant period but to ship's life time till scrapped.
Key Quote: “Our ICT expertise in marine IoT, big data, and artificial intelligence has played a key role in HGS’s digital transformation strategy. HGS recently contracted eMARINE to supply its marine IoT data platform to HGS for their Total Care Service to Hyundai built ships in operation at sea.” Ung Gyu Kim, Chairman & CEO
Disclosure
eMARINE Global (OTC: EMRN) is a client of RedChip Companies. RedChip Companies, Inc. owns 613,000 shares of EMRN common stock.
|
|
| |
|
| U.S. Small Caps at Crucial Juncture |
| |
|
Smaller cap U.S. equities are on the Street’s radar right now, both for their relative performance and their technical picture.
The Russell 2000 index of small-cap stocks has fallen 1.5% since February 22, while the S&P 500 index, which tracks the biggest American companies, has risen 4%.
The performance of the Russell 2000 is often seen as reflecting sentiment about the U.S. economy, as the companies tend to be more domestically focused versus the larger, more international firms in the S&P 500. So, if the Russell is underperforming, it could mean softening expectations for American growth.
Earlier this month, Societe Generale SA strategists recommended betting against the Russell, while going long on its components with strong balance sheets, as a way to position protectively against a credit crunch.
|
|
| |
|
| Level Brands (NYSE American: LEVB) Announces Results of its 2019 Annual Shareholder Meeting |
| |
|
Level Brands (NYSE American: LEVB), owner and operator of the nationally recognized consumer cannabidiol (CBD) brand cbdMD, held its annual shareholder meeting on April 19, 2019. At the meeting, shareholders approved the company’s name change and other key matters. The name change is expected to occur on May 1, 2019, and the company also expects its ticker symbol on the NYSE American will change to YCBD at the same time.
Key Quote: “We are honored to make history. cbdMD will be the first U.S. based CBD company to trade on a U.S. national exchange. cbdMD continues to lead the way in the CBD industry in America. Our products are connecting with our customers in a way that is truly incredible. As an everyday user of cbdMD, I can tell you it helps me. And I’m not alone. It is incredibly gratifying to receive so many testimonials about how our products are helping our customers live better lives. Likewise, our customers continue to shower praise on our pet products as our pet lines continue to expand.” Martin A. Sumichrast, Chairman & CEO
Disclosure
Level Brands (NYSE American: LEVB) is a client of RedChip Companies. LEVB agreed to pay RedChip a monthly cash fee of between $5,000 and $15,000, and 5,000 shares of Rule 144 stock for RedChip investor awareness services. Additionally, the CEO of RedChip Companies owns 13,500 shares of LEVB.
|
|
| |
|
| BioSig (NASDAQ: BSGM) Completes Successful Patient Cases at Greenville Memorial Hospital |
| |
|
BioSig Technologies (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address unmet needs for the electrophysiology (EP) marketplace, announced that the Company successfully conducted patient cases using the PURE EP(tm) System at Greenville Memorial Hospital, part of Prisma Health System.
Key Note: PURE EP(tm) System is the Company’s FDA cleared proprietary electrocardiogram and intracardiac signal acquisition and amplification system.
Key Quote: “Positive clinical experience with our technology in the medical centers with diverse patient profiles is key to a strong market positioning. We believe that more clinical experience, delivered by the next set of centers scheduled to use PURE EP(tm) System in the coming months, will allow us to gain additional insight into our key value proposition and deliver on our strategic goals in the second half of the year.” Kenneth L. Londoner, Chairman and CEO of BioSig Technologies
The Backstory: BioSig Technologies is a medical technology company developing a proprietary biomedical signal processing platform designed to improve the electrophysiology (EP) marketplace (www.biosig.com). Led by a proven management team and a veteran, independent Board of Directors, Los Angeles-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The technology has been developed to address an unmet need in a large and growing market.
|
|
| |
|
| Immuron (NASDAQ: IMRN) Appoints CEO Dr. Gary S. Jacob to Board of Directors |
| |
|
Immuron Limited (NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunoglobulin therapeutics for the treatment of gut mediated diseases, announced the appointment of Dr. Gary S. Jacob, CEO of Immuron Ltd. to the Board of Directors as a Director.
Dr. Gary S. Jacob, founding CEO of Synergy Pharmaceuticals and co-inventor of TRULANCE® (an FDA-approved drug), came on board as CEO in November 2018. Dr. Jacob brings more than 30 years’ experience in the pharmaceutical and biotechnological industries, having raised more than USD $500M of capital in the public markets.
The Backstory: Immuron Limited (ASX: IMC, NASDAQ: IMRN), is an Australian biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of inflammatory mediated and infectious diseases. Immuron has a novel and safe technology platform with one commercial asset generating revenue. In Australia, Travelan® is a listed medicine on the Australian Register for Therapeutic Goods (AUST L 106709) and is indicated to reduce the risk of travelers’ diarrhea (TD), reduce the risk of minor gastro-intestinal disorders and is antimicrobial. In Canada, Travelan® is a licensed natural health product (NPN 80046016) and is indicated to reduce the risk of TD. In the U.S., Travelan® is sold as a dietary supplement for digestive tract protection. Immuron’s lead clinical candidate, IMM-124E, is presently in Phase II trials in Severe Alcoholic Hepatitis (SAH) and Pediatric Nonalcoholic Fatty Liver Disease (NAFLD). The company now has plans to develop a U.S. registration dossier for IMM-124E for TD. Immuron’s second clinical-stage asset, IMM-529, targets Clostridium difficile Infections (CDI), and is presently in a clinical trial in CDI patients. These products, together with the Company’s other preclinical immunotherapy pipeline products currently under development targeting immune-related and infectious diseases, are anticipated to meet pressing needs in the global immunotherapy market.
Disclosure
Immuron Ltd. (NASDAQ: IMRN) is a client of RedChip Companies, Inc. IMRN agreed to pay RedChip Companies, Inc. a monthly cash fee for (3) months of investor awareness services.
|
|
| |
|
| Zosano (NASDAQ: ZSAN) Announces the Publication of an Analysis of Acute Treatments for Migraine in Headache: The Journal of Head and Face Pain |
| |
|
Zosano Pharma Corporation (NASDAQ: ZSAN), a clinical-stage biopharmaceutical company, announced the peer-reviewed publication of a review and analysis of recently completed trials using newly FDA-recommended endpoints in the acute treatment of migraine.
The review article, led by Stanford Assistant Professor of Neurology, Nada Hindiyeh, MD., was published in Headache, titled “Review of Acute Treatment of Migraine Trial Results With the New FDA Endpoints: Design Implications for Future Trials.”
The Backstory: Qtrypta is Zosano’s proprietary formulation of zolmitriptan delivered utilizing its proprietary ADAM technology. Zosano's ADAM technology consists of titanium microneedles coated with drug, and in the case of Qtrypta, its formulation of zolmitriptan. The drug-coated microneedles penetrate into the epidermis and dermis, where the investigational drug is dissolved and enters into the bloodstream. In February 2017, the Company announced statistically significant results from the ZOTRIP pivotal study, in which the 3.8mg dose of Qtrypta met both co-primary endpoints, achieving pain freedom and most bothersome symptom freedom at 2 hours. In November 2017, the Company announced the initiation of its long-term safety study evaluating Qtrypta and expects to file an NDA for Qtrypta in the fourth quarter of 2019.
|
|
| |
|
| |
| Quote of the Week |
| |
"Higher returns, of course, come with more risk...the trade off is, yes, you get long-term outperformance ... but the volatility of returns is greater... That's the price you pay if you want exposure to a better-performing asset class."
- Harold Stonechipher, Founder of Pre-Paid Legal |
|
|
|
|
|
|
|
| About RedChip |
| |
| RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on small-cap and mid-cap companies. Since 1992, RedChip has delivered concrete, measurable results for its clients through the most comprehensive service platform in the industry for small-cap and mid-cap companies. These services include a worldwide distribution network for its stock research written by analysts holding the CFA designation; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated over 2.3 million unique investor views; quarterly global online institutional and retail investor conferences that reach over 10,000 investors annually; "The RedChip Money Report" television show which airs in 100 million homes across the U.S. on The Family Channel; a weekly newsletter delivered to 60,000 investors; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more. |
| |
| RedChip Disclosure |
| |
RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.
RedChip Visibility is a division of RedChip Companies, Inc. and offers research services to paying clients. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that the RedChip Companies Inc. is an investor relations firm hired by certain Companies to increase investor awareness to the small-cap equity community.
Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print.
We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov and view RedChip’s Disclosures. |
|
| |
|
|
| |
|
|
Copyright © 2019 RedChip Companies, Inc. All Rights Reserved.
You are receiving this message because this email address has signed up to receive News Alerts.
|
|
|
|
|
|
